ARTL Company Profile and Key Details

Q: Who are the executives of ARTL?

Dr. Andrew Yates Ph.D.Senior Vice President & Chief Scientific OfficerDr. Steven D. ReichChief Medical OfficerMr. Jason H. BaybuttSenior Vice President of Fin.Mr. Gregory D. Gorgas M.B.A.Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director

NASDAQ : ARTL

Artelo Biosciences

$1.84

-0.5-21.37%

At Close 4:00 PM

$2.11

+0.27+14.66%

After-Market 05:00 PM

60.16

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Artelo Biosciences, Inc. (ARTL) stock declined over -21.37%, trading at $1.84 on NASDAQ, down from the previous close of $2.34. The stock opened at $2.18, fluctuating between $1.77 and $2.18 in the recent session.

Stock Snapshot

2.34

Prev. Close

4.02M

Market Cap

1.77

Day Low

-0.05

P/E Ratio

-37.56

EPS (TTM)

-2.07

Cash Flow per Share

2.18

Open

2.18M

Number of Shares

2.18

Day High

99.37%

Free Float in %

4.94

Book Value

7.03M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 15, 2026	2.24	2.34	1.77	1.84	6.68M
May 14, 2026	2.35	2.44	2.30	2.34	82.75K
May 13, 2026	2.40	2.40	2.30	2.31	59.52K
May 12, 2026	2.46	2.46	2.31	2.40	65.12K
May 11, 2026	2.51	2.64	2.40	2.42	87.3K
May 08, 2026	2.63	2.66	2.51	2.54	89.83K
May 07, 2026	2.65	2.78	2.64	2.68	102.36K
May 06, 2026	3.02	3.04	2.78	2.78	142.21K
May 05, 2026	3.22	3.23	3.05	3.08	97.09K
May 04, 2026	3.39	3.55	3.18	3.30	124.74K
Apr 30, 2026	3.36	3.49	3.20	3.49	133.41K
Apr 29, 2026	3.51	3.60	3.37	3.41	83.37K
Apr 28, 2026	3.66	3.72	3.37	3.57	682.81K
Apr 27, 2026	4.01	4.12	3.68	3.77	295.31K
Apr 23, 2026	3.92	4.12	3.85	3.99	393.08K
Apr 22, 2026	3.77	4.24	3.73	4.00	616.97K
Apr 21, 2026	4.05	4.33	4.02	4.05	567.86K
Apr 20, 2026	5.13	5.64	4.48	4.53	32.71M
Apr 17, 2026	4.73	4.86	4.40	4.44	94.34K
Apr 16, 2026	5.10	5.24	4.18	4.86	442.39K

Contact Details

Solana Beach, CA 92075

United States

https://www.artelobio.com 858 925 7049

About Company

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Stock Peers

ARGX

-22.81-2.77%

argenx SE$799.32 REGN

-14.62-2.05%

Regeneron Pharmaceuticals, Inc.$698.25 UTHR

-7.21-1.25%

United Therapeutics Corporation$568.58 MDGL

-16.2-3.00%

Madrigal Pharmaceuticals, Inc.$523.69 VRTX

-13.68-3.04%

Vertex Pharmaceuticals Incorporated$436.73 PRAX

-2.94-0.85%

Praxis Precision Medicines, Inc.$342.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-10.01-3.16%

Krystal Biotech, Inc.$306.29 ALNY

-6.47-2.20%

Alnylam Pharmaceuticals, Inc.$286.98 ASND

-4.99-2.03%

Ascendis Pharma A/S$240.50

Frequently Asked Questions

What is the current Artelo Biosciences, Inc. (ARTL) stock price?

Artelo Biosciences, Inc. (NASDAQ: ARTL) stock price is $1.84 in the last trading session. During the trading session, ARTL stock reached the peak price of $2.18 while $1.77 was the lowest point it dropped to. The percentage change in ARTL stock occurred in the recent session was -21.37% while the dollar amount for the price change in ARTL stock was - $0.50.

ARTL's industry and sector of operation?

The NASDAQ listed ARTL is part of Biotechnology industry that operates in the broader Healthcare sector. Artelo Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ARTL?

Dr. Andrew Yates Ph.D.
Senior Vice President & Chief Scientific Officer
Dr. Steven D. Reich
Chief Medical Officer
Mr. Jason H. Baybutt
Senior Vice President of Fin.
Mr. Gregory D. Gorgas M.B.A.
Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director

How ARTL did perform over past 52-week?

ARTL's closing price is 3.96% higher than its 52-week low of $1.77 where as its distance from 52-week high of $85.80 is -97.86%.

How many employees does ARTL have?

Number of ARTL employees currently stands at 6.

Link for ARTL official website?

Official Website of ARTL is: https://www.artelobio.com

How do I contact ARTL?

ARTL could be contacted at phone 858 925 7049 and can also be accessed through its website. ARTL operates from 505 Lomas Santa Fe, Solana Beach, CA 92075, United States.

How many shares of ARTL are traded daily?

ARTL stock volume for the day was 7.03M shares. The average number of ARTL shares traded daily for last 3 months was 3.43M.

What is the market cap of ARTL currently?

The market value of ARTL currently stands at $4.02M with its latest stock price at $1.84 and 2.18M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	1.07
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	6
Beta	1.07
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ARTL Company Profile and Key Details

Artelo Biosciences

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Earnings & Analyst Outlook

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook